Home Search
red blood cell - search results
If you're not happy with the results, please do another search
Type 1 diabetes: A serious chronic disease
University of Oulu’s Professor Riitta Veijola discusses the impact of Type 1 diabetes on society and the challenges associated with tackling the disease
Chronic lymphocytic leukemia: getting closer to a cure?
Associate Professor of Medical Genetics, Silvia Deaglio, highlights the research strides being made in the fight against chronic lymphocytic leukemia
Shining a light on brain functionality after stroke
Professor Saverio Pavone, of the European Laboratory for Non Linear Spectroscopy and Department of Physics highlights the latest advances in stroke research
Jammed inert particles and their role in understanding cancer
Professor Roberto Cerbino of the University of Milan discusses how cell tissues may be ruled by the same laws of jammed inert particles
Preventing Alzheimer’s disease with neuroimaging methods
Ai-Ling Lin of the Lin Brain Lab details how neuroimaging research can be used to reduce brain aging and the impact of Alzheimer’s disease
Blockchain will have the biggest impact on the public sector
John Bertrand, Digital Value Engineer at SAP talks about the value of blockchain and how it can benefit government as well as local authorities
Blockchain seems to be everywhere and nowhere all at once. It is based on distributed ledger technology (DLT) – also known as a shared database or...
Visualising the human genome like beads on a string
The human genome is composed of over 3 billion letters, here Dr Yuval Ebenstein, Principal Investigator, Tel Aviv University sheds light on it.
Transforming regenerative medicine into an opportunity for patients
Antonino Tramonte, Managing Director, Swiss Institute for Regenerative Medicine outlines how regenerative medicine can help patients.
Improvements in stroke care, awareness and early detection
Frederic Destrebecq, Vinciane Quoidbach and Alison Turner at the European Brain Council discuss improvements in stroke care, awareness-raising and early detection
Stroke is a leading cause of disability and mortality among adults. It is the third cause of death worldwide and the first cause of acquired disability.1 Despite improvements in...
The IMI programmes driving access to innovative medicines
By providing the infrastructure to support drug discovery, the IMI is accelerating access to innovative medicines, as the EFPIA highlights here
Innovation is the lifeblood of the pharmaceutical industry, providing us with the potential to cross new therapeutic frontiers to bring novel medicines to market that benefit patients and deliver...
Spontaneous brain plasticity brings hope after stroke
Stroke is a major cause of morbidity and mortality worldwide, but research into spontaneous brain plasticity could offer hope for recovery
Among the main causes of brain injury, ischemic or haemorrhagic stroke burdens the life of hundreds of thousands of people each year. Approximately half of the survivors are susceptible...
Ebenstein lab develops new technologies for studying genomes
Researchers in the Ebenstein lab for nanobiophotonics at Tel Aviv University are using epigenetic marks to study genomic variation
Although the DNA sequence is identical in all the cells of our body, cells from different tissues look and function in a completely different form. Epigenetics is responsible for this. Epigenetic...
Treatments for prostate cancer: Pros and cons
Dr Sumith A Kularatne, vice-president of R&D at On Target Laboratories, explores the pros and cons of various existing treatments for prostate cancer
Prostate cancer (PCa) is the second leading cause of cancer-related deaths in men, with about 1.1 million new cases and approximately 307,000 fatalities per year globally. This...
Diagnostic services for cancer are under growing pressure
Improving cancer survival relies on earlier diagnosis, but diagnostic services are under growing pressure, as Cancer Research UK Policy Manager Sara Bainbridge explains
There are more than 200 different types of cancer, so when someone sees their doctor with possible symptoms, getting the right diagnosis can be complicated. Diagnosing cancer...
Membranous nephropathy: A renal auto-immune disease
Professor Pierre Ronco describes advances in our understanding of membranous nephropathy and the promise of precision medicine to treat the disease
A rare disease which affects the kidney, membranous nephropathy is the second-most common cause of nephrotic syndrome, which is characterised by massive protein loss in the urine. The consequence...
ProteoLipins and LipoFishins: Novel nutraceuticals and their effects
Dr Ramón Cacabelos, President of EuroEspes Biomedical Research Center, highlights the potential benefits of novel nutraceuticals including ProteoLipins
Pharmacotherapy is a fundamental cornerstone in the global fight against disease worldwide. The value of drug production has grown four times more rapidly than the world’s income. High-income countries dominate in world...
Why non-coding RNA research for cancer is key
Jo Vandesompele, Chief Scientific Officer at Biogazelle, outlines how non-coding RNA research for cancer can help develop a more targeted treatment approach
DNA is the hereditary code that is passed on from parents to their children. Every cell inside our body has the same code that contains the blueprint of...
Stroke and neuroplasticity: A multiscale insight
After a stroke, neuroplasticity contributes to spontaneous recovery; exactly how, Professor Francesco Pavone and colleagues are investigating
Cerebral stroke often leaves victims with significant psychical and physical impairments – from vision problems to aphasia and motor deficits. It is the number one cause of adult disability worldwide, and have a...
A spatio-temporal mathematical model for cancer
Zhihui Wang1,2 and Vittorio Cristini1,2 outline how they have developed a model to help predict cancer treatment outcomes…
The physical properties of a tumour’s microenvironment influence a drug’s ability to penetrate and kill tumour cells. Some of these properties can be potential obstructions to drug diffusion, increasing the tumour’s resistance...
Placing education, research and innovation at the heart of Ireland
Dr. Ana Terrés, Director of Research Support at Dublin City University (DCU), looks at how DCU innovates for societal impact and contributes to Ireland’s economic recovery…
Dublin City University (DCU) is a young and dynamic university which aims to have an impact on Irish society, not only by placing...